By Rishika Sadam and Kashish Tandon Dec 12 (Reuters) - Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg ...

Americans without health insurance could be paying more than 10 times as much for the weight-loss drugs.

It continues to be pounded by competition and challenges coming from numerous directions.

In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of ...

A medical expert warned of the side effects of the newly launched weight loss drug Ozempic.

Danish Novo Nordisk launched its blockbuster treatment injection Ozempic in three forms in 0.25 mg, 0.5 mg and 1 mg in the ...

Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...

New Delhi, 13 Dec 2025 (ANI): Novo Nordisk launches Ozempic in India for diabetes, weight management at ₹2,200/week ...

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

Novo Nordisk has launched Ozempic in India at ₹2,200 per week, expanding diabetes treatment options even as patent disputes ...

Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in 'FlexTouch Pen' - an easy-to-use, once-weekly pen device, at ...

India's GLP-1 race intensifies with the launch of Ozempic ...